…s disease. The remaining had miscellaneous underlying diseases. Secondary RP showed prolonged ischemic time in minutes during rewarming in t…
SSc
This disease is selected. Its supporting articles are shown below.
Articles mentioning SSc
251 articles · page 19 of 21…large SSc patient cohort.Material and Methods Data from Italian Systemic Sclerosis Progression InvestiGation (SPRING) registry were retrospectivel…
…Introduction Scleroderma (SSc) is a rare fibrosing multisystem disease with high rates of morb…
…s an increase of mRSS of >5 units or >25% increase in mRSS, and Pulmonary Hypertension (PH) was confirmed by RHC (mPAP >25 mmHg). Statistical analysis…
…Introduction Fibrotic interstitial lung disease (ILD), with no definitive treatment that stabilizes or regresses the …
… CCL19, CXCL9, CXCL10, and CXCL11 (Myriad RBM) in patients with systemic sclerosis (SSc) fulfilling the 2013 ACR/EULAR classification criteria, who were…
…medicine represents a very innovative and promising approach to systemic sclerosis (SSc). The most fascinating regenerative tecnique is the autologous f…
…Introduction Treatment goals for systemic sclerosis (SSc) include controlling disease activity, limiting progression of o…
… soluble EphrinB2. It is elevated in fibrosing diseases such as systemic sclerosis (SSc) where it appears to be a key driver of fibrosis via myofibrobla…
… Anti-centromere antibodies (ACA) identify a distinct subset of systemic sclerosis (SSc) patients, traditionally associated with a less fibrotic p…
…l lung disease (ILD) and potential benefits on skin fibrosis in systemic sclerosis (SSc). This study aims to evaluate the safety and effectiveness of TC…
…Introduction Systemic sclerosis (SSc) is a rare rheumatic disease characterized by fibrosis of skin a…